PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors
Yap, T.A., Choudhury, A.D., Hamilton, E., Rosen, L.S., Stratton, K.L., Gordon, M.S., Schaer, D., Liu, L., Zhang, L., Mittapalli, R.K., Zhong, W., Soman, N., Tolcher, A.W.
Published in ESMO open (01.09.2024)
Published in ESMO open (01.09.2024)
Get full text
Journal Article
Varying efficacy of superdisintegrants in orally disintegrating tablets among different manufacturers
Mittapalli, R.K., Sha Qhattal, H.S., Lockman, P.R., Yamsani, M.R.
Published in Pharmazie (01.11.2010)
Published in Pharmazie (01.11.2010)
Get full text
Journal Article